Publicaciones en colaboración con investigadores/as de University of Oxford (7)

2024

  1. The Human Phenotype Ontology in 2024: phenotypes around the world

    Nucleic acids research, Vol. 52, Núm. D1, pp. D1333-D1346

2010

  1. Effect of nateglinide on the incidence of diabetes and cardiovascular events

    New England Journal of Medicine, Vol. 362, Núm. 16, pp. 1463-1476

  2. Effect of valsartan on the incidence of diabetes and cardiovascular events

    New England Journal of Medicine, Vol. 362, Núm. 16, pp. 1477-1490

  3. The first clinical case of a mutation at residue K185 of Kir6.2 (KCNJ11): A major ATP-binding residue

    Diabetic Medicine, Vol. 27, Núm. 2, pp. 225-229

2006

  1. Functional analysis of six Kir6.2 (KCNJ11) mutations causing neonatal diabetes

    Pflugers Archiv European Journal of Physiology, Vol. 453, Núm. 3, pp. 323-332